Latest Share Chat

Synairgen Share News (SNG)

Synairgen Information

Buy SNG Shares
Add SNG to Watchlist
Add SNG to Alert

Share Price Information for Synairgen (SNG)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 7.55

Bid: 6.52

Ask: 7.48

Change: 0.00 (0.00%)

Spread: 0.96 (14.724%)

Open: 7.55

High: 0.00

Low: 0.00

Prev. Close: 7.55

Last checked at -

AGM, EGM Calendar - Week Ahead

Mon, 15th Jun 2015 14:52

UK AGM, EGM Calendar

Tuesday, June 16

Plant Health Care

Servoca

Cyan Holdings

StratMin Global Resources

Inspired Energy

Huntsworth

HSS Hire Group

Premier Farnell

NMC Health

Christie Group

Whitbread

UK Commercial Property Trust

Wednesday, June 17

Futura Medical

Forum Energy

Central Asia Metals

Cyprotex

JD Sports Fashion

International Consolidated Airlines Group

Thursday, June 18

Taliesin Property Fund

Tower Resources

Goldenport Holdings

BlackRock Smaller Companies Trust

Petropavlovsk

Evraz

HC Slingsby

Aureus Mining

Friday, June 19

Charlemagne Capital

Eland Oil and Gas

Avocet Mining

Horizon Discovery

Peninsular Gold

W Resources

Iofina

NextEnergy Solar Fund

Monday, June 22

Synairgen

Tarsus Group

Inspired Capital

Utima Networks

NetScientific

More News

25 Jan 2021 19:18

TRADING UPDATES: Intuitive Plots GBP250,000 Investment In Microsaic

20 Jan 2021 21:16

IN BRIEF: Synairgen Recruits Covid-19 Patients Into Phase II Trial

13 Jan 2021 10:24

Synairgen Doses First Patient In Covid-19 Treatment Trial

11 Jan 2021 20:54

COVID SCIENCE-COVID-19 patients still have symptoms 6 months later; interferon may be helpful treatment after all

By Nancy LapidJan 11 (Reuters) - The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.Half a year later, COVID-19 pat...

18 Dec 2020 12:08

LONDON MARKET MIDDAY: FTSE 100 Rises As Crunch Brexit Talks Dent Pound

18 Dec 2020 11:06

Synairgen Gets Fast Track Designation From US FDA For Covid-19 Vaccine

18 Dec 2020 10:29

Synairgen makes solid progress with Covid-19 treatment

(Sharecast News) - Respiratory drug development company Synairgen updated the market on its phase 3 trial design evaluating SNG001 as a treatment for patients with Covid-19 on Friday, as well as positive progress on its regulatory path.

18 Nov 2020 13:59

finnCap Interim Profit More Than Doubles; Chair To Step Down

13 Nov 2020 14:28

Synairgen surges on positive results for Covid-19 treatment

(Sharecast News) - Synairgen shares surged on Friday after data from trials of its inhaled Covid-19 treatment, SNG001, published in The Lancet Respiratory Medicine, showed positive results in hospitalised patients.

13 Nov 2020 10:24